Enterprise League logo
S

Sitryx

Oxford, United Kingdom (UK) · Science and Engineering

Source

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

Nov 2025

Work here? Claim this profile

Overview

Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.

Most teams do this before shortlisting


Contact Details

info@sitryx.com

Oxford, United Kingdom (UK)

Founded

2018

Employees

30-50

Categories

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after Sitryx

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.